Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women
Effects of Hormone Replacement Therapy on Arthralgia in Postmenopausal Women: a Randomized, Double-blind Controlled Trial
研究概览
详细说明
研究类型
注册 (预期的)
阶段
- 阶段2
联系人和位置
学习地点
-
-
Rio Grande Do Sul
-
Porto Alegre、Rio Grande Do Sul、巴西
- 招聘中
- Comitê de Ética em Pesquisa do Hospital de Clínicas de Porto Alegre
-
接触:
- Maria Celeste Osório Wender, Ph.D
- 电话号码:+55513359-8117
- 邮箱:mceleste@ufrgs.br
-
接触:
- Fernanda Vargas Ferreira, Ph.D
- 电话号码:+55513359-8117
- 邮箱:fernandaferreira@unipampa.edu.br
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- age between 45 and 55 years
- chronic arthralgia related to climacteric
- regular mammography and pap smear test in the last twelve months
- availability to attend hormone replacement therapy
- maximum of ten years of amenorrhea according to the criteria of Stages of Reproductive Aging Workshop (STRAW)
- without use of hormone replacement therapy, at least, previous six months
- no contraindication to hormone replacement therapy (current or past of breast and / or cervical cancer, severe current or recent heart disease, thromboembolism, hypertension with no control, metabolic diseases (but stable thyroid disease) and endometrial hyperplasia to be enlightened
- Informed consent
Exclusion Criteria:
- autoimmune diseases
- visceral pain (chronic pelvic pain, dyspareunia, irritable bowel syndrome)
- systemic diseases (rheumatic, neurological, oncology, sexually transmitted infection)
- body mass index of 30 or greater
- soy diet
- abuse of alcohol and drugs
- large surgeries
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Conjugated Equine Estrogen
Thirty-six healthy postmenopausal women aged between 45 and 55 years will receive 0,625 mg/day conjugated equine estrogen (CEE) for 12 weeks. These 1 active pill containing conjugated equine estrogen, 0,625 mg will be provided by a laboratory with no trademark identification. The bottles will be numbered in code by a pharmaceutist not involved directly in study and they will donated to volunteers. During the intervening period, use of conjugated equine estrogen, there will be blinding. After this phase, blinding will be interrupted in order to identify volunteers who used the active drug. |
Use of conjugated equine estrogen for 12 weeks.
Adherence will be monitored during periodical hospital visits in order to receive pills.
其他名称:
|
|
安慰剂比较:Placebo
Thirty-six healthy postmenopausal women aged between 45 and 55 years will receive placebo pills, identical in size, shape and color to the active drug, via oral administration, for 12 weeks. The bottles, without trademark identification, will be numbered in code by a pharmaceutist not involved directly in study and they will donated to volunteers. During the intervening period, use of placebo, there will be blinding. After this phase, blinding will be interrupted in order to identify volunteers who used the active drug and placebo. |
Use of placebo for 12 weeks.
Adherence will be monitored during periodical hospital visits in order to receive pills.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Arthralgia
大体时间:6 months
|
Arthralgia´ll be measured by numeric scale (0-10).
|
6 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Climacteric symptoms
大体时间:6 months
|
Climacteric symptoms´ll be evaluated by Menopause Rating Scale - Brazilian Version.
The score increases point by point with increasing severity of subjectively perceived symptoms in each of the 11 items.
|
6 months
|
|
Level of physical activity
大体时间:6 months
|
Level of physical activity´ll be evaluated by International Physical Activity Questionnaire - Brazilian Version whose three levels of physical activity are low, moderate and high.
|
6 months
|
|
Pain Catastrophizing
大体时间:6 months
|
Pain Catastrophizing´ll be evaluated by Pain Catastrophizing - Brazilian Version into three subscales being magnification, rumination, and helplessness.
The higher the score, the more catastrophizing thoughts are present.
|
6 months
|
|
Health-related quality of life
大体时间:6 months
|
Quality of life´ll be evaluated by Women´s Health Questionnaire - Brazilian Version (somatic symptoms, depressed mood, cognitive difficulties, anxiety and fear, sexual functioning, vasomotor symptoms, sleep problems, menstrual problems, and self-perceived attraction).
The higher the score, the more pronounced the suffering and dysfunction.
|
6 months
|
|
Depression
大体时间:6 months
|
Depression´ll be evaluated by Beck Depression Inventory - Brazilian Version.
The standard cut-off scores are minimal, mild, moderate and severe depression.
|
6 months
|
|
Anxiety
大体时间:6 months
|
Anxiety´ll be evaluated by Beck Anxiety Inventory - Brazilian Version.
The standard cut-off scores are minimal, mild, moderate and severe depression.
|
6 months
|
|
Quality of sleep
大体时间:6 months
|
Quality of sleep´ll be evaluated by Pittsburgh Sleep Quality Index - Brazilian Version.
Lower scores denote a healthier sleep quality.
|
6 months
|
合作者和调查者
调查人员
- 首席研究员:Maria Celeste Osório Wender, Ph.D、Hospital de Clinicas de Porto Alegre
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 16-0235
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.